Maximize value from
limited sample
Enacting precision oncology studies to move potential therapies beyond today's
standard of care requires a comprehensive view of a tumor's underlying genomic
landscape.
One method meeting this challenge is comprehensive genomic profiling (CGP), a next
generation sequencing (NGS) approach that:
Assess
500+ genes simultaneously in a
single assay, preserving precious
sample
Assess
500+ genes simultaneously in a
single assay, preserving precious
sample
Assess
500+ genes simultaneously in a
single assay, preserving precious
sample
Assess
500+ genes simultaneously in a
single assay, preserving precious
sample
Identify genetic
alterations in
of samples90%
Large-cohort studies show that comprehensive genomic profiling
has the potential to identify relevant genetic alterations in up to
90% of samples.